rss
Arch Dis Child Fetal Neonatal Ed 85:F105-F109 doi:10.1136/fn.85.2.F105
  • Original article

Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies

Table 1

Initial dried blood spot and follow up assays in 12 babies with persistently increased octanoylcarnitine and at least one copy of A985G

  • Patients 1–11 were assigned a diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency, and patient 12 was considered to be a carrier at low risk of developing symptoms. +/+, homozygous for A985G; +/−, heterozygous for A985G; Ole, oleate; Myr, myristate; O:M, oleate to myristate ratio; C4, butyrylcarnitine; C6, hexanoylcarnitine; C8, octanoylcarnitine; C10, decanoylcarnitine; C10:1, decenoylcarnitine; ND, not detected; NP, not performed; NI, not increased; +++, grossly elevated; ++, moderately increased; +, slightly increased; TR, trace increase.

This Article

Latest from Education & Practice

Latest from Education & Practice

Register for free content

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Fetal & Neonatal.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Paediatrics and Paediatric Surgery Jobs

    Paediatrics and Paediatric Surgery Jobs